申请人:Kandula Mahesh
公开号:US20150353522A1
公开(公告)日:2015-12-10
The invention relates to the compounds of formula I or its pharmaceutical acceptable salts, as well as polymorphs, solvates, enantiomers, stereoisomers and hydrates thereof. The pharmaceutical compositions comprising an effective amount of compounds of formula I; and methods for treating or preventing moderate to severe pain, may be formulated for oral, buccal, rectal, topical, transdermal, transmucosal, intravenous, parenteral administration, syrup, or injection. Such compositions may be used to treatment of muscle pain, spasticity, neuropathic pain, fibromyalgia, post-operative pain, muscle spasticity, headache, chronic pain, sub-chronic pain and local pain.
本发明涉及公式I的化合物或其药物可接受的盐,以及其多晶形、溶剂合物、对映体、立体异构体和水合物。该药物组合物包括有效量的公式I化合物;以及治疗或预防中度至严重疼痛的方法,可以制成口服、颊下、直肠、局部、经皮、经黏膜、静脉、肌肉注射、糖浆或注射剂。这些组合物可用于治疗肌肉疼痛、痉挛、神经性疼痛、纤维肌痛、术后疼痛、头痛、慢性疼痛、亚慢性疼痛和局部疼痛。